Cambridge Trust CO Becton Dickinson & CO Transaction History

Cambridge Trust CO

  • $2.6 Billion
  • Q1 2024

A detailed history of Cambridge Trust CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cambridge Trust CO holds 23,937 shares of BDX stock, worth $5.42 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
23,937
Previous 68,631 65.12%
Holding current value
$5.42 Million
Previous $16.7 Million 64.6%
% of portfolio
0.23%
Previous 0.71%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024
SELL
$233.45 - $247.73 $10.4 Million - $11.1 Million
-44,694 Reduced 65.12%
23,937 $5.92 Million
Q4 2023

Jan 31, 2024
BUY
$232.24 - $267.23 $9,057 - $10,421
39 Added 0.06%
68,631 $16.7 Million
Q3 2023

Oct 26, 2023
SELL
$254.9 - $283.59 $1.39 Million - $1.55 Million
-5,458 Reduced 7.37%
68,592 $17.7 Million
Q2 2023

Jul 25, 2023
SELL
$238.39 - $265.32 $439,352 - $488,984
-1,843 Reduced 2.43%
74,050 $19.5 Million
Q1 2023

May 12, 2023
SELL
$229.71 - $259.35 $164,242 - $185,435
-715 Reduced 0.93%
75,893 $18.8 Million
Q4 2022

Jan 09, 2023
SELL
$218.29 - $256.91 $382,225 - $449,849
-1,751 Reduced 2.23%
76,608 $19.5 Million
Q3 2022

Nov 07, 2022
SELL
$51.03 - $264.23 $16,227 - $84,025
-318 Reduced 0.4%
78,359 $17.5 Million
Q2 2022

Aug 16, 2022
SELL
$234.74 - $275.42 $280,044 - $328,576
-1,193 Reduced 1.49%
78,677 $19.4 Million
Q1 2022

May 12, 2022
BUY
$243.64 - $270.48 $270,684 - $300,503
1,111 Added 1.41%
79,870 $21.2 Million
Q4 2021

Feb 14, 2022
BUY
$230.08 - $250.94 $510,317 - $556,584
2,218 Added 2.9%
78,759 $19.8 Million
Q3 2021

Nov 23, 2021
BUY
$232.72 - $256.47 $277,634 - $305,968
1,193 Added 1.58%
76,541 $18.8 Million
Q3 2021

Nov 16, 2021
SELL
$232.72 - $256.47 $302,536 - $333,411
-1,300 Reduced 1.7%
75,348 $18.5 Million
Q2 2021

Aug 16, 2021
SELL
$232.65 - $254.58 $437,614 - $478,864
-1,881 Reduced 2.4%
76,648 $18.6 Million
Q1 2021

May 14, 2021
SELL
$232.09 - $256.88 $8.27 Million - $9.16 Million
-35,653 Reduced 31.22%
78,529 $19.1 Million
Q4 2020

Jan 27, 2021
SELL
$221.92 - $245.94 $2.68 Million - $2.97 Million
-12,063 Reduced 9.56%
114,182 $28.6 Million
Q3 2020

Nov 03, 2020
BUY
$215.77 - $276.76 $166,358 - $213,381
771 Added 0.61%
126,245 $29.4 Million
Q2 2020

Aug 05, 2020
BUY
$219.9 - $263.41 $511,267 - $612,428
2,325 Added 1.89%
125,474 $35.5 Million
Q1 2020

May 04, 2020
BUY
$195.69 - $279.01 $107,042 - $152,618
547 Added 0.45%
123,149 $28.3 Million
Q4 2019

Feb 04, 2020
BUY
$236.45 - $266.82 $232,430 - $262,284
983 Added 0.81%
122,602 $33.3 Million
Q3 2019

Nov 06, 2019
SELL
$230.58 - $256.08 $212,594 - $236,105
-922 Reduced 0.75%
121,619 $30.8 Million
Q2 2019

Jul 29, 2019
SELL
$217.4 - $246.08 $37,175 - $42,079
-171 Reduced 0.14%
122,541 $0
Q1 2019

Apr 22, 2019
BUY
$206.05 - $248.17 $68,614 - $82,640
333 Added 0.27%
122,712 $30.6 Million
Q4 2018

Feb 04, 2019
SELL
$204.73 - $257.93 $74,726 - $94,144
-365 Reduced 0.3%
122,379 $27.6 Million
Q3 2018

Oct 22, 2018
BUY
$233.07 - $256.0 $50,809 - $55,808
218 Added 0.18%
122,744 $32 Million
Q2 2018

Aug 06, 2018
SELL
$208.1 - $233.85 $64,719 - $72,727
-311 Reduced 0.25%
122,526 $29.4 Million
Q1 2018

Apr 27, 2018
BUY
$205.46 - $240.27 $337,981 - $395,244
1,645 Added 1.36%
122,837 $26.6 Million
Q4 2017

Jan 24, 2018
BUY
$189.0 - $222.64 $455,490 - $536,562
2,410 Added 2.03%
121,192 $0
Q3 2017

Nov 02, 2017
BUY
$186.89 - $198.9 $22.2 Million - $23.6 Million
118,782
118,782 $0

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.6B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email